At HLTH, Ian Khan sits down with Michelle Zimmerman, co-founder of Previvor Edge, to discuss proactive cancer prevention. Previvor Edge delivers personalized, clinical-grade hereditary cancer risk profiles and prevention plans, aiming to move cancer care from reactive to proactive. Zimmerman shares how earlier risk insight and tailored plans can change outcomes for people with elevated genetic risk. The conversation explores how precision prevention can reshape the fight against cancer.